New therapies for neuromuscular diseases in 2018. (2019)

First Author: Shah AM
Attributed to:  A Programme for ALS Care in Europe (ALS-CarE) funded by ESRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1474-4422(18)30414-9

PubMed Identifier: 30563673

Publication URI: http://europepmc.org/abstract/MED/30563673

Type: Journal Article/Review

Volume: 18

Parent Publication: The Lancet. Neurology

Issue: 1

ISSN: 1474-4422